These results demonstrated that metformin may inhibit lung adenocarcinoma cell proliferation by altering PTEN and mTOR expression, but we were unable to explore metformin potentially inhibit tumor angiogenesis, metastasis, and chemotherapy resistance. This evidence concerns the gene PTEN and lung adenocarcinoma.